WHO Recommends Two New Ebola Vaccines for DRC Trial
The WHO has recommended two new vaccine candidates developed by Oxford University and Moderna for an ongoing clinical trial in the Democratic Republic of the Congo…reports Asian Lite News Desk The World Health Organization (WHO) has recommended adding two new vaccine candidates to an ongoing clinical trial in the Democratic Republic of the Congo (DRC), marking the first time vaccines specifically developed against the Bundibugyo virus will be tested during an outbreak of the disease. The candidates, ChAdOx1, developed by the University of Oxford in partnership with the Serum Institute of India, and Moderna’s mRNA-1469, have been recommended for further



























